Hook and thesis
Nu Holdings Ltd. (NU) delivered another expansionary quarter but the market punished the stock after the company flagged margin pressure and heavier spending on U.S. expansion. That knee-jerk reaction opened a clear, risk-defined trade: the business is still scaling quickly, with sizable net interest income and customer growth, but short-term sentiment has swung negative enough to offer an asymmetric reward-to-risk setup.
My thesis is straightforward: buy into the post-earnings weakness on the view that revenue and customer momentum remain intact and that margins can re-stabilize over the next several weeks as investors digest the investment profile. Entry: $12.50. Target: $16.00. Stop: $11.60. Trade horizon: mid term (45 trading days).
What Nu does and why the market should care
Nu is a digital banking holding company built out of Brazil and expanding across Latin America and into the U.S. The company monetizes a large customer base through lending, transaction fees and higher-yielding interest activities. Market participants care because Nu combines rapid top-line growth with large addressable markets in Brazil, Mexico and Colombia, and because it is now scaling net interest income - a margin lever that can materially change profitability as the loan book grows.
Recent fundamentals that matter
Recent quarterly disclosures and commentary show the growth engine is still running. Nu reported $5.32 billion in revenue in Q1 2026, up 42% year-over-year, and recorded record net interest income of $3.25 billion. The company reported roughly 135 million customers globally in the quarter, a scale advantage that feeds both deposit and lending growth.
On a trailing basis the company trades with a market capitalization of about $61.8 billion and a reported P/E near 20.0, reflecting the market’s willingness to pay for sustained growth; the balance between multiple and growth is what will determine returns from here. The stock’s 52-week trading band runs from $11.71 to $18.98, so today’s price sits closer to the low end of that range, and the technicals show the stock is under pressure - 10-day SMA sits at $12.80 and the 50-day SMA around $14.12, with RSI near 38 suggesting the name is not yet oversold to a technical extreme.
Why I think the earnings sell-off is an opportunity
- Growth remains strong. Revenue growth of 42% YoY and $3.25 billion of net interest income underscore that Nu is converting scale into interest-bearing assets.
- Scale reduces unit economics risk. With ~135 million customers, customer acquisition costs can be amortized over a large base and cross-sell economics improve over time.
- Market reaction was focused on margins and near-term spending. Those are binary-to-gradual storylines - margin recovery or at least stabilization is plausible over weeks to months, and U.S. spending is an intentional strategic choice, not a surprise structural failure.
- Short interest and heavy short-volume around the earnings date indicate a crowded negative trade that could exacerbate squeezes if sentiment shifts back positive.
Valuation framing
At roughly $61.8 billion market cap and a trailing P/E near 20.0, Nu is priced for continued high growth but not perfection. Analysts in prior coverage have modeled multi-year EPS growth in the double digits; one published perspective from 03/26/2026 suggested analyst expectations of roughly 36% annual EPS growth through 2028 and a forward P/E near 17.8 in that scenario. That math means the company’s current valuation is reasonable if revenue and margin recovery happen within the next few quarters; it becomes expensive if margin compression proves permanent.
Qualitatively, Nu is cheaper than the frothier fintech names at peak valuations and is priced more like a growth bank - you pay for earnings that are still scaling rather than for speculative product adoption alone.
Catalysts to push the stock higher
- Margin stabilization as funding costs normalize and the loan book mix continues to favor higher-yielding assets.
- Evidence that customer growth picks back up or stronger engagement metrics (higher ARPU, cross-sell lifts) reported in the next quarterly update.
- Positive updates on the U.S. expansion trajectory - slower near-term profitability impact but clearer path to scale.
- Analyst upgrades or multiple expansion as the post-earnings panic fades and the stock re-rates closer to growth-banks peers.
Trade plan - clear, actionable, disciplined
| Action | Price | Horizon | Rationale |
|---|---|---|---|
| Entry | $12.50 | Mid term (45 trading days) | Buy into post-earnings weakness near the 10-day SMA and below the 20-day SMA to capture mean reversion and margin stabilization. |
| Target | $16.00 | Target is near the mid-to-high $15s where the 50-day SMA and prior consolidation area offer resistance; represents ~28% upside from entry. | |
| Stop | $11.60 | Stop placed below the 52-week low area to limit capital loss if the downtrend continues and margins deteriorate further. |
Timeframe reasoning: mid term (45 trading days) gives enough runway for quarterly guidance cadence, investor digestion of margin commentary and early signs of U.S. investment outcomes. It is long enough to let volatility from short-covering and technical mean reversion play out, but short enough to remain responsive if macro or company-specific deterioration accelerates.
Position-sizing and risk management
This trade sets a hard stop at $11.60. A conservative position-size would risk no more than 1-2% of portfolio capital on this idea. If you get filled at $12.50, the risk per share to the stop is $0.90; size accordingly. Consider trimming partial profits at $14.00 to lock in gains if the stock rallies quickly, and move the stop to breakeven at that point.
Counterarguments and how I would respond
- Counterargument: The earnings miss reflects structural margin deterioration - funding costs and competition could keep margins under pressure and choke EPS growth. Response: That is a valid scenario; the stop at $11.60 protects against sustained margin erosion. I want to see sequential improvements in net interest income per loan dollar or narrower deposit costs before adding size beyond an initial allocation.
- Counterargument: U.S. expansion spending could meaningfully dilute near-term returns and fail to produce a material customer ramp. Response: This is execution risk. The trade banking the softening reaction presumes the market already discounts the near-term dilution. If Nu reports materially worse U.S. metrics or guidance cuts, I would exit on the stop and reassess the long-term thesis.
Risks - at least four to balance the thesis
- Macroeconomic risk in Latin America - currency swings, inflation, or recessions could increase credit losses and reduce lending volumes.
- Margin pressure - higher funding costs or a less favorable loan mix could keep net interest income from scaling fast enough to satisfy earnings expectations.
- Execution risk on U.S. expansion - higher-than-expected marketing and product costs could delay profitability improvements.
- Valuation risk - the stock trades at a premium versus mature banks on growth. If growth decelerates, multiple compression could drive significant downside.
- Sentiment and liquidity - heavy recent short activity and large average volumes mean the stock can move quickly in either direction and experience whipsaw behavior around news events.
What would change my mind
I would abandon this trade if Nu issues explicit guidance that revenue growth will slow materially below the high-teens to 20% range or if net interest income trends down sequentially. Similarly, a clear inability to stabilize funding costs or persistent deterioration in credit metrics would invalidate the thesis. On the positive side, a follow-up quarter showing margin improvement and accelerating ARPU or loan yields would strengthen the case and justify adding to the position.
Bottom line: Nu still looks like a high-quality growth bank at a reasonable price relative to its historical expectations. The market overreacted to margin noise and put the stock in a price zone where a disciplined long with clear risk controls is attractive. Entry $12.50, target $16.00, stop $11.60 - mid term (45 trading days) trade.
Key monitoring points
- Net interest income trends and any commentary on funding costs in the next company update.
- Customer metrics - monthly active customers, average revenue per user, and loan book growth rates.
- U.S. business metrics - customer acquisition cost and early deposit/lending behavior.
- Macro data in Brazil and Mexico - inflation and FX moves that could affect credit costs.
Execution matters here. Nu is not a speculative coin-flip; it is a scaling financial franchise with measurable levers. The recent miss created a window to buy scale at a discount, but only with disciplined stops and a clear plan to reassess if margins prove structurally weaker than management is signaling.